CEFPROZIL
- Product NDC
- 57297-401
- 11-digit product format
- 572970401
- Labeler code
- 57297
- Product ID
- 57297-401_7d716a14-301a-440b-8205-7e14542ad016
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- CEFPROZIL
- Dosage form
- POWDER, FOR SUSPENSION
- Route
- ORAL
- Labeler
- LUPIN LIMITED
- Application
- ANDA065261
- Marketing category
- ANDA
- Marketing start
- 2005-12-01
- Marketing end
- 0000-00-00
- Substance
- CEFPROZIL
- Active strength
- 125 mg/5mL
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 57297-401-01 | 2024-12-03 | C162847 | 48780-1 | 9d75b9cf-ea65-f424-e053-dadaa90a57ce | 0eac1c30-6fe4-410e-a0ce-11966e4c08fe |
| 57297-401-02 | 2024-12-03 | C162847 | 48780-1 | 9d75b9cf-ea65-f424-e053-dadaa90a57ce | 0eac1c30-6fe4-410e-a0ce-11966e4c08fe |
| 57297-401-03 | 2024-12-03 | C162847 | 48780-1 | 9d75b9cf-ea65-f424-e053-dadaa90a57ce | 0eac1c30-6fe4-410e-a0ce-11966e4c08fe |
| 57297-401-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-ea65-f424-e053-dadaa90a57ce | 0eac1c30-6fe4-410e-a0ce-11966e4c08fe |
| 57297-401-02 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-ea65-f424-e053-dadaa90a57ce | 0eac1c30-6fe4-410e-a0ce-11966e4c08fe |
| 57297-401-03 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-ea65-f424-e053-dadaa90a57ce | 0eac1c30-6fe4-410e-a0ce-11966e4c08fe |